NO20070845L - Fremgangsmate for fremstilling av losartan - Google Patents

Fremgangsmate for fremstilling av losartan

Info

Publication number
NO20070845L
NO20070845L NO20070845A NO20070845A NO20070845L NO 20070845 L NO20070845 L NO 20070845L NO 20070845 A NO20070845 A NO 20070845A NO 20070845 A NO20070845 A NO 20070845A NO 20070845 L NO20070845 L NO 20070845L
Authority
NO
Norway
Prior art keywords
preparation
losartan
novel
relates
intermediates suitable
Prior art date
Application number
NO20070845A
Other languages
English (en)
Inventor
Yaping Wang
Yonggang Li
Yulin Li
Guojun Zheng
Yi Li
Original Assignee
Ratiopharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ratiopharm Gmbh filed Critical Ratiopharm Gmbh
Publication of NO20070845L publication Critical patent/NO20070845L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelsen gjelder en ny fremgangsmåte for fremstilling av losartan, et imidazolderivat med det kjemiske navnet 2-n-butyl-4-klor-5-hydroksymetyl-l-{[2'-(1H-tetrazol-5yl)bifenyl-4]metyl}irnidazol så vel som dens farmakologisk virksomme salter. Videre gjelder oppfinnelsen nye mellomprodukter som er egnet for fremstilling av losartan og også nye fremgangsmåter for fremstilling av mellomforbindelser som er egnet for fremstilling av losartan. Et aspekt av oppfinnelsen er en fremgangsmåte for fremstilling av en forbindelse med den generelle formel (1) som kan oppstå ved fremstillingen av losartan ifølge oppfinnelsen som mellomprodukt.
NO20070845A 2005-02-03 2007-02-14 Fremgangsmate for fremstilling av losartan NO20070845L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005005047 2005-02-03
PCT/DE2006/000164 WO2006081807A2 (de) 2005-02-03 2006-02-02 Verfahren zur herstellung von losartan

Publications (1)

Publication Number Publication Date
NO20070845L true NO20070845L (no) 2007-11-02

Family

ID=36097110

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070845A NO20070845L (no) 2005-02-03 2007-02-14 Fremgangsmate for fremstilling av losartan

Country Status (13)

Country Link
US (1) US20090111994A1 (no)
EP (2) EP1844019B1 (no)
CN (1) CN101133035A (no)
AT (2) ATE441637T1 (no)
CA (1) CA2595962A1 (no)
DE (1) DE502006004733D1 (no)
ES (1) ES2332328T3 (no)
IL (1) IL184800A (no)
NO (1) NO20070845L (no)
RU (1) RU2412940C2 (no)
SI (1) SI1844019T1 (no)
UA (1) UA90131C2 (no)
WO (1) WO2006081807A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090018332A1 (en) * 2007-06-28 2009-01-15 Wyeth Processes For Preparing Bicyclic Oxazine Carboxaldehyde and Beta-Lactamase Inhibitors
KR101472686B1 (ko) * 2013-07-09 2014-12-16 씨제이헬스케어 주식회사 벤즈이미다졸 유도체의 제조방법
CN103351352B (zh) * 2013-07-15 2015-10-21 南通市华峰化工有限责任公司 一种5-苯基四氮唑新合成方法
CN115368389A (zh) * 2021-05-19 2022-11-22 奥锐特药业(天津)有限公司 一种Filgotinib中间体的制备方法
CN113929666A (zh) * 2021-09-30 2022-01-14 宁波美诺华药业股份有限公司 一种洛沙坦立体异构体杂质合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
CA1334092C (en) 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4820843A (en) 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
SG52709A1 (en) * 1989-06-30 1998-09-28 Du Pont Substituted imidazoles
RU2067581C1 (ru) * 1989-06-30 1996-10-10 Е.И.Дюпон Де Немур Энд Компани Аралкилзамещенные имидазолы, обладающие противогипертоническим действием, способ их получения и фармацевтический состав, обладающий ингибирующей активностью в отношении ангиотензина ii
US5411980A (en) * 1989-07-28 1995-05-02 Merck & Co., Inc. Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists
DE4132633A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Cyclisch substituierte imidazolyl-propensaeurederivate
AU685898B2 (en) * 1993-12-23 1998-01-29 Du Pont Merck Pharmaceutical Company, The Polymorphs of losartan and the process for the preparation of form II of losartan
WO2003093262A2 (en) 2002-04-29 2003-11-13 Teva Pharmaceutical Industries Ltd. Processes for preparing losartan and losartan potassium
WO2004085426A1 (en) * 2003-03-27 2004-10-07 Hetero Drugs Limited Novel crystalline forms of candesartan cilexetil

Also Published As

Publication number Publication date
RU2412940C2 (ru) 2011-02-27
IL184800A (en) 2011-06-30
WO2006081807A3 (de) 2007-05-18
EP2080756A2 (de) 2009-07-22
RU2007129814A (ru) 2009-03-10
US20090111994A1 (en) 2009-04-30
IL184800A0 (en) 2007-12-03
EP2080756A3 (de) 2011-02-16
WO2006081807A2 (de) 2006-08-10
EP1844019A2 (de) 2007-10-17
EP1844019B1 (de) 2009-09-02
ATE441637T1 (de) 2009-09-15
CN101133035A (zh) 2008-02-27
DE502006004733D1 (de) 2009-10-15
ES2332328T3 (es) 2010-02-02
AT9840U1 (de) 2008-04-15
CA2595962A1 (en) 2006-08-10
SI1844019T1 (sl) 2010-01-29
UA90131C2 (en) 2010-04-12

Similar Documents

Publication Publication Date Title
NO20091858L (no) Hydrobenzamid derivater som inhibitorer av HSP90
MX2009007334A (es) Compuestos de amida del acido indol-3-carboxilico 6-substituido que tienen actividad antagonista biologica del receptor esfingosina-1-fosfato (s1p).
WO2007112322A3 (en) Indole compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity
NO20076660L (no) Fremgangsmate for fremstilling av rosuvastatin og mellomprodukter
NO20082338L (no) Pyrimidinderivater for behandling av avvikende cellevekst
NO20082263L (no) Organiske forbindelser
WO2005080384A3 (en) Benzimidazole derivative and use as aii receptor antagonist
NO20080789L (no) 1,4-benzotiazepin 1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende denne forbindelsen og anvendelse derav som et hypolipid
WO2008062905A3 (en) Heteromonocyclic compound and use thereof
WO2007056517A3 (en) Pharmaceutical salts and polymorphs of n- (5-chl0r0-2-pyridinyl) -2- [ [4- [ (dimethylamino) iminomethyl] benzoyl] amino] -5-meth oxy-benzamide, a factor xa inhibitor
NO20073701L (no) Nye fremgangsmater for fremstilling av et 2H-kromen
MX335989B (es) Compuesto adecuado para el tratamiento de sinucleopatias.
EA200970604A1 (ru) Новое промежуточное соединение и способ, используемый для получения {2-[1-(3,5-бис-трифторметилбензил)-5-пиридин-4-ил-1н-[1,2,3]триазол-4-ил]пиридин-3-ил}-(2-хлорфенил)метанона
NO20070845L (no) Fremgangsmate for fremstilling av losartan
NO20065327L (no) Fremgangsmate for fremstilling av derivarer av 5-'4-(2-hydroksy-propyl)-3,5-dihydro-3H'1, 2,4(triazin-2-yl)-benzamid.
NO20075618L (no) Novel compounds as GLP-1 Agonists
NO20063268L (no) Fremgangsmate til fremstilling av 1-(2S,3S)-2-benzhydryl-N-(5-tert-butyl-2-metoksybenzyl)quinuklidin-3-amin
NO20082005L (no) Syntese av renininhibitorer omfattende en cyklotilfoyelsesreaksjon
WO2007032019A3 (en) Process for preparing valsartan
WO2008100651A3 (en) Preparation of darifenacin and its salts
NO20053753L (no) Karboksylsyreforbindelser.
NO20070972L (no) Benzyloksyderivater som MAOB-inhibitorer
NO20063111L (no) Fremgangsmate for fremstilling av tiazolpyrimidiner
BRPI0607085A2 (pt) derivados de oximas heterocìclicos, o respectivo processo de preparação e a respectiva utilização como agentes hipoglicemiantes e hipolipemiantes
NO20065789L (no) Cinnamidforbindelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application